Stay updated with breaking news from Rob Winder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On July 7, 2022, invoX Pharma Limited ("invoX"), a wholly owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK) commenced a cash tender offer for all of the issued and
Proposed ~US$161 million all-cash acquisition to accelerate invoX's strategy to build Sino Biopharm's International Biopharmaceutical R&D Platform outside of China, transforming the lives of patients worldwideThe
Press release content from Business Wire. The AP news staff was not involved in its creation.
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated
Investegate announcements from Scancell Hlds, Change of Registered Holder of Shares